Carl Zeiss Meditec (ETR:AFX) PT Set at €140.00 by Deutsche Bank

Deutsche Bank set a €140.00 ($162.79) target price on Carl Zeiss Meditec (ETR:AFX) in a report issued on Tuesday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

AFX has been the topic of several other research reports. Hauck & Aufhaeuser set a €110.00 ($127.91) price target on shares of Carl Zeiss Meditec and gave the company a neutral rating in a report on Friday, January 31st. Berenberg Bank set a €114.00 ($132.56) price target on shares of Carl Zeiss Meditec and gave the company a neutral rating in a report on Thursday, January 23rd. Nord/LB set a €132.00 ($153.49) price target on shares of Carl Zeiss Meditec and gave the company a buy rating in a report on Wednesday, December 11th. HSBC set a €109.00 ($126.74) price target on shares of Carl Zeiss Meditec and gave the company a neutral rating in a report on Tuesday, December 10th. Finally, Independent Research set a €93.00 ($108.14) price target on shares of Carl Zeiss Meditec and gave the company a sell rating in a report on Tuesday, December 10th. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. Carl Zeiss Meditec currently has a consensus rating of Hold and a consensus price target of €111.14 ($129.24).

ETR AFX opened at €108.90 ($126.63) on Tuesday. Carl Zeiss Meditec has a one year low of €71.25 ($82.85) and a one year high of €122.10 ($141.98). The company’s 50 day moving average price is €115.83 and its 200 day moving average price is €106.77. The company has a debt-to-equity ratio of 4.06, a quick ratio of 3.01 and a current ratio of 3.84. The firm has a market capitalization of $9.74 billion and a price-to-earnings ratio of 57.44.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Further Reading: What is a resistance level?

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.